Elevated aptt in a cancer patient

29 Apr 2014 INTRODUCTION: Hypercoagulability due to high coagulation factor to an increased risk of venous thromboembolism (VTE) in cancer patients. time ( aPTT) can be used to broadly screen for elevated levels of relevant The serum level of CP activity was dependent on the stage of the disease. The CP activity Only one patient with advanced cancer had APTT shortened to 23 s

29 Nov 2012 The study comprised 110 lung cancer patients. Although prolonged aPTT and high levels of D-dimer was associated with worse survival, the

4 Oct 2010 The most frequent thromboembolic complications in cancer patients are levels were increased in breast cancer patients but PT and APTT property among cancer patients in Sudan by determining D-dimer level, cancer patients than the controls (p value (0.000). mean APTT and PT were also 13 Nov 2014 Also known as: Activated Partial Thromboplastin Time aPTT APTT . To identify coagulation factor deficiency if the PTT is prolonged, further studies can then Based on carefully obtained patient histories, the PTT and PT tests are . Extensive cancer (ovarian, pancreatic, colon), except when the liver is

A shortened activated partial thromboplastin time predicts the risk of

Patients amp Families Black arrow right Another test, the activated partial thromboplastin time (APTT) test, may be used to find out if the right dose of heparin is The results of PLT, PT, aPTT, D-dimer and AT III were reported as mean . Survival analysis of patients with lung cancer based on plasma level of D-dimer

10 Jan 2012 The PT test is often performed periodically to monitor patients who regularly nodes dissected (for example, breast cancer patients) on the test side (the Prolonged PT or APTT resultsmeaning the blood takes too long to Cancer patients often have positive D-dimers and FDP, usually representing low- grade, HEPARIN NEUTRALIZATION (performed if APTT is prolonged)